12
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Undifferentiated Arthritis and Spondylarthropathy as a Major Problem of Diagnosis and Classification

Pages 54-62 | Published online: 12 Jul 2009

References

  • Lawrence J S., Bennett PH. Benign polyarthritis. Ann Rheum Dis 1960; 19: 20–3
  • Nasrallah N S., Masi A T., Chandler R W., Fcigenbaum S L., Kaplan SB. HLA-B27 antigen and rheumatoid factor negative (seronegative) peripheral arthritis. Studies in younger patients with early-diagnosed arthritis. Am J Med 1977; 63: 379–86
  • Isomäki H, Raunio J, Von Essen A, Hämeenkorpi R. Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol 1978; 7: 188–92
  • Nissilä M, Isomäki H, Kareela K, Kiviniemi P, Martio J, Sarna S. Prognosis of inflammatory joint disease. Scand J Rheumatol 1983; 12: 33–8
  • Amor B. Reiter's syndrome and reactive arthritis. Clin Rheumatol 1983; 2: 315–9
  • Parker J D., Calder V, Capell HA. An acute arthritis clinic-one year's experience. Br J Rheum 1985; 24: 210
  • Fletcher M R., Scott JT. Chronic monoarticular synovitis. Diagnostic and prognostic features. Ann Rheum Dis 1975; 34: 171–6
  • Genth E, Peuckert H, Brude E, Hehl M, Hartl W. HLA-B27 positive oligoarthritis. Z Rheumatol 1978; 37: 313–28
  • Bitter T, Jeannet M, De Haller E, Lejeune M. Persistent yet reversible asymmetric pauciarthritis (PRAP): a B27-associated cluster. Ann Rheum Dis 1979; 38: 84–91, suppl.
  • Eastmond C J., Rajah S M., Tovcy D, Wright V. Seronegative pauciarticular arthritis and HLA-B27. Ann Rheum Dis 1980; 39: 231–4
  • Calin A, Marks SH. The case against seronegative rheumatoid arthritis. Am J Med 1981; 70: 992–4
  • Fcigenbaum S L., Masi A T., Schoon CM. Classification studies of rheumatoid factor negative (seronegative) peripheral arthritis. Arth Rheum 1981; 24: 99, suppl.
  • Burns T, Marder A, Becks E, Sullivan L, Calin A. Undifferentiated spondylarthritis: a nosological missing link?. Arth Rheum 1982; 25: 142, suppl.
  • Kareela K, Tiitinen S, Luukkainen R. Long-term prognosis of monoarthritis. A follow-up study. Scand J Rheumatol 1983; 12: 374–6
  • Prakash S, Mehra N K., Bheargava S, Malaviya AN. HLA-B27 related unclassified seronegative spondylarthropathies. Ann Rheum Dis 1983; 43: 640–3
  • Kareela K, Sarna S. Seronegative oligoarthritis. Scand J Rheumatol 1984; 52: 9–12, suppl.
  • Tunn E J., Bacon P A., Salmon M. Prediction of persistence in an early synovitis clinic. Br J Rheum 1986; 25: 79, suppl.
  • Schattenkirelmer M, Krüger K. Natural course and prognosis of HLA-B27 positive oligoarthritis. Clin Rheumatol 1987, in press
  • Zeidler H, Wagener P, Eckert G, et al. HLA-B27 in possible ankylosing spondylitis with peripheral arthritis. Rheumatol Int 1982; 2: 35–40
  • Zeidler H, Mau H R., Mau W, Freyschmidt J, Majewski A, Deicher H. Evaluation of early diagnostic critieria including HLA-B27 for ankylosing spondylitis in a follow-up study. Z Rheumatol 1985; 44: 248–53
  • Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Deicher H. Outcome of possible ankylosing spondylitis in a 10 years' follow-up study. Clin Rheumatol 1987, in press
  • Baudoin P, Landureau M. Critères de diagnostic de la pelvospondylite rhumatismales sans atteinte radiologique des sacro-iliaques. Proposition de mise a jour. Rev Rhum 1979; 49: 403–12
  • Lakomek H J., Will H, Zech M, Krüskemper HL. A new serologic marker in ankylosing spondylitis. Arth Rheum 1984; 27: 961–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.